Tari Leslie has filed 6 insider transactions across 1 company since March 2024.
Most recent transaction: a sale of 1773 shares of Cidara Therapeutics, Inc. ($CDTX) on March 11, 2025.
Activity breakdown: 0 open-market purchases and 3 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 11, 2025 | Cidara Therapeutics, Inc. | $CDTX | Tari Leslie | CHIEF SCIENTIFIC OFFICER | S | Common Stock | 1773 | $21.96 | 16,288.0000 | 10,953,490 | 9.82% | 0.02% |
| Sept. 30, 2024 | Cidara Therapeutics, Inc. | $CDTX | Tari Leslie | CHIEF SCIENTIFIC OFFICER | A | Employee Stock Option (right to buy) | 150224 | $0.00 | 150,224.0000 | 0 | 9999.99% | 0.00% |
| Sept. 11, 2024 | Cidara Therapeutics, Inc. | $CDTX | Tari Leslie | CHIEF SCIENTIFIC OFFICER | S | Common Stock | 909 | $11.64 | 17,861.0000 | 0 | 4.84% | 0.00% |
| March 15, 2024 | Cidara Therapeutics, Inc. | $CDTX | Tari Leslie | CHIEF SCIENTIFIC OFFICER | A | Common Stock | 111250 | $0.00 | 371,415.0000 | 0 | 42.76% | 0.00% |
| March 15, 2024 | Cidara Therapeutics, Inc. | $CDTX | Tari Leslie | CHIEF SCIENTIFIC OFFICER | A | Employee Stock Option (right to buy) | 222500 | $0.00 | 222,500.0000 | 0 | 9999.99% | 0.00% |
| March 11, 2024 | Cidara Therapeutics, Inc. | $CDTX | Tari Leslie | CHIEF SCIENTIFIC OFFICER | S | Common Stock | 21029 | $0.67 | 260,165.0000 | 0 | 7.48% | 0.00% |